approval
saveREBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
community read0 votes
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalFeb 27, 2026 · 217d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalAug 28, 2023 · 1131d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalJul 8, 2022 · 1547d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalApr 3, 2020 · 2373d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalNov 8, 2019 · 2520d ago
comments(0)
5-min edit window · permanent after that